Healthy Skepticism Library item: 7644
Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.
Publication type: Journal Article
Dewar JC, Hall IP.
Personalised prescribing for asthma--is pharmacogenetics the answer?
J Pharm Pharmacol 2003 Mar; 55:(3):279-89
http://www.ingentaconnect.com/content/rpsgb/jpp/2003/00000055/00000003/art00001?token=004810963048296a7c2849266d656c595c5f3b3b47675648663b707b7476457a31e78616
Abstract:
An individual’s response to anti-asthma medication is likely to arise from a complex interaction between social, environmental and inherited factors. Studies indicate that genetic factors may account for 60-80% of the heterogeneity in treatment responsiveness in asthmatics. Identifying the genetic variants responsible may potentially lead to the development of novel treatments, improved effectiveness in the use of existing treatments and better prediction of efficacy in phase II and III trials. This article will briefly outline the current methods of identifying relevant treatment-responsive genes and their genetic variants. The pharmacogenetics of the main asthma treatment groups will then be reviewed in detail. Finally, the impact of pharmacogenetics on the pharmaceutical industry, and clinical practice in the future will be discussed.
Keywords:
Anti-Asthmatic Agents/therapeutic use*
Asthma/drug therapy*
Asthma/epidemiology
Asthma/genetics*
Drug Resistance
Great Britain
Humans
Pharmacogenetics*
Prescriptions, Drug*
